Page 7 - Prospective Study News Today

A broad overview of the role vitamin D in the immune system, especially in the pathogenesis & treatment of IBD, & its possible role in predicting relapse.

/PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical"), a global medical device company revolutionizing the field of neuromodulation with an emerging...

Human Rights Watch has carefully reviewed SB 1338[1] and the proposed framework for the Community Assistance, Recovery and Empowerment (CARE) Court created by CalHHS,[2] and must respectfully voice our strong opposition. CARE Court promotes a system of involuntary, coerced treatment, enforced by an expanded judicial infrastructure, that will, in practice, simply remove unhoused people with perceived mental health conditions from the public eye without effectively addressing those mental health c...

What Is the Prostate, and How Common Is the Cancer? It's a walnut-size gland that lies at the ...

Is running bad for your knees? Evidence suggests that runners are actually less likely to get osteoarthritis – heres why

Human Rights Watch has carefully reviewed SB 1338 and the proposed framework for the Community Assistance, Recovery and Empowerment (CARE) Court created by CalHHS. In its current form, it promotes a system of involuntary, coerced treatment, enforced by an expanded judicial infrastructure, that will, in practice, simply remove unhoused people with perceived mental health conditions from the public eye without effectively addressing those mental health conditions and without meeting the urgent nee...

Human Rights Watch has carefully reviewed AB 2830 and the proposed framework for the Community Assistance, Recovery and Empowerment (CARE) Court created by CalHHS, and must respectfully voice our strong opposition. CARE Court promotes a system of involuntary, coerced treatment, enforced by an expanded judicial infrastructure, that will, in practice, simply remove unhoused people with perceived mental health conditions from the public eye without effectively addressing those mental health conditi...

Maximally sustaining IL-6 suppression in a chronic disease like NMOSD and enabling subcutaneous dosing every four weeks. Positive Phase III results for ENSPRYNG, as both monotherapy and in... | March 25, 2022

First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presentedEvrysdi data continue

/PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study...